| EMEP
Esomeprazole

Description:
Esomeprazole is the S-isomer of Omeprazole, proton
pump inhibitor. Esomeprazole suppresses gastric acid secretion
by specific inhibition of the H+/K+-ATPase
in the gastric parietal cell. By acting specially on the proton
pump, esomeprazole blocks the final step in acid production,
thus reducing gastric acidity.
Composition:
Each enteric coated tablet contains Esomeprazole
magnesium trihydrate INN equivalent to Esomerprazole 20
mg.
Indictaions:
¨ For the treatment of heart burn and other symptoms
associated with GERD
¨ For the healing of erosive esophagitis.
¨ For maintenance of healing of erosive esophagitis
¨ In duodenal ulcer
¨ In combination with amoxycillin, clarithromycin,
esomeprazole is used for the treatment of H.
pylori infection and duodenal ulcer disease to eradicate
H. pylori.
Dosage & administration:
Esomeprazole tablet should be taken one hour
before meal.
Recommended adult dosage schedule of Emep
| Indication |
Dose |
Frequency |
| Gastroesophageal Reflux Disease (GERD) |
| Healing of Erosive Esophagitis |
20 mg or 40 mg |
Oncedaily for 4 to 8 weeks* |
| Maintenance of Healing of
Erosive Esophagitis |
20 mg |
Once daily |
| Symptomatic Gastroesophageal
Reflux Disease |
20 mg |
Once daily for 4 weeks |
| H. pylori
eradication reduces the risk of duodenal ulcer recurrence |
| Triple
therapy |
| Emep |
40 mg |
Once daily for 10 days |
| Amoxycillin |
1000 mg |
Twice daily for 10 days |
| Clarithromycin |
500 mg |
Twice daily for 10 days |
* The majority of patients are healed within
4 to 8 weeks. For patients who do not heal after 4-8 weeks,
an additional 4-8 weeks treatment may be considered.
Contraindications:
Esomeprazole is contraindicated in patients who
have known hypersensitivity to Esomeprazole or any component
of the formulation.
Side-effects:
In general, esomeprazole is well tolerated in
both short and long term use. Adverse events reported with esomeprazole
include headache, diarrhoea, nausea, flatulence, abdominal pain,
constipation and dry mouth.
High risk groups:
Pregnancy: Pregnancy Category: B; There are no
adequate and well controlled studies in pregnant women. This
drug should be used during pregnancy only if clearly needed.
Nursing mother: The excretion of Esomeprazole
in milk has not been studied. Because Esomeprazole is likely
to be excreted in human milk, a decision should be made whether
to discontinue nursing or to discontinue the drug, taking into
account the importance of the drug to the mother.
Children: Not recommended.
Geriatric patients: No dosage adjustment is necessary.
Renal insufficiency: No dosage adjustment is
necessary.
Hepatic insufficiency: No dosage adjustment is
necessary in patients with mild to moderate liver impairment.
For patients with severe liver impairment a dose of 20 mg of
Esomeprazole should not be exceeded.
Drug Interactions:
Esomeprazole is extensively metabolized in the
liver. Drug interactions studies have shown that Esomeprazole
does not have any clinically significant interactions with phenytoin,
warfarin, quinidine, clarithromycin or amoxycillin. Esomeprazole
may interfere with the absorption of drugs where gastric pH
is an important determinant of bioavailability (e.g. ketoconazole,
iron salts and digoxin).
Storage:
Protect from light. Store in a cool and dry place.
Keep out of the reach of children.
Packing:
Each box contains 6x10’s tablets in Alu-Alu pack. |